Diet Pills Market Scope, Analysis, and Trends by 2028
Diet Pills Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1.13 Billion |
Market Size by 2028 | US$ 2.27 Billion |
Global CAGR (2021 - 2028) | 10.4% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Diet Pills Market Segmentation
The global diet pills market is segmented based on product type, application, age group, distribution channel, and geography. Based on product type, the market is segmented into prescription, over the counter drugs, and herbal supplements. Based on application, the diet pills market is segmented into appetite suppression, fat blocking, metabolism raising pills, and others. Based on age range, the diet pills market is bifurcated into teenagers and adults. Based on distribution channel, the diet pills market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies & drug stores. By geography, the diet pills market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.
Company Profiles
- Novo Nordisk A/S
- Gelesis
- VIVUS LLC
- Chong's Health Care
- GlaxoSmithKline plc.
- Pfizer Inc. (Arena Pharmaceutical GmbH)
- Iovate Health Sciences International Inc.
- Zoller Laboratories
- Currax Pharmaceuticals LLC.
- TEVA PHARMACEUTICAL INDUSTRIES LTD